GQ Bio - About the company
GQ Bio is an acquired company based in Hamburg (Germany), founded in 2012. It operates as a Developer of gene therapies for orthopedic treatment. The company has 82 active competitors, including 24 funded and 9 that have exited. Its top competitors include companies like Flexion Therapeutics, Formation Bio and Rocket Pharma.
Company Details
Developer of gene therapies for orthopedic treatment. It offers a gene therapy vector platform that develops transformative medicines which include GQ-501, GQ-401, and GQ-203 to treat chronic diseases such as osteoarthritis and intervertebral disc degeneration.
- Website
- gq-biotx.com/home-2.html
- Social
- Email ID
- *****@gq-biotx.com
- Phone Number
- +49 **********
Key Metrics
Founded Year
2012
Location
Hamburg, Germany
Stage
Acquired
Investors
Ranked
24th among 82 active competitors
Employee Count
2 as on Dec 31, 2022
Similar Companies
Exit Details
Acquired by Pacira (Feb 27, 2025)
Legal entities associated with GQ Bio
GQ Bio is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Feb 04, 2020 | - | 2 (as on Dec 31, 2022) | - | |
Oct 24, 2012 | - | - |
GQ Bio's acquisition details
GQ Bio got acquired by Pacira on Feb 27, 2025 at an acquisition amount of $32M.
Click here to take a look at GQ Bio's acquisition in detail
Sign up to download GQ Bio's company profile
GQ Bio's funding and investors
GQ Bio has not raised any funding rounds yet. GQ Bio has 1 institutional investor.
View details of GQ Bio's funding rounds and investors
GQ Bio's founders and board of directors
Founder? Claim ProfileGQ Bio's employee count trend
GQ Bio has 2 employees as of Dec 22. The total employee count is 100.0% more than what it was in Dec 21. Here is GQ Bio's employee count trend over the years:
Uncover GQ Bio's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
GQ Bio's Competitors and alternates
Top competitors of GQ Bio include Flexion Therapeutics, Formation Bio and Rocket Pharma. Here is the list of Top 10 competitors of GQ Bio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Flexion Therapeutics 2007, Woburn (United States), Acquired | Developer of therapies for the treatment of musculoskeletal disorders | $62M | 67/100 | |
2nd |  Formation Bio 2016, New York City (United States), Series D | AI-powered drug discovery platform for various diseases | $608M | 64/100 | |
3rd |  Rocket Pharma 2015, New York City (United States), Public | Developer of gene-modified cell therapies for the treatment of rare diseases | - | 58/100 | |
4th |  Eupraxia Pharmaceuticals 2012, Vancouver (Canada), Public | Sustained released formulation for osteoarthritis | $2.44M | 55/100 | |
5th |  Akamis Bio 2006, Abingdon (United Kingdom), Series D | Developer of gene therapeutics for oncology | $179M | 53/100 | |
6th |  Biosplice 2008, San Diego (United States), Series D | Developer of therapeutics modulating alternative splicing by targeting CLK/DYRK family kinases | $778M | 53/100 | |
7th |  MRM Health 2020, Ghent (Belgium), Series B | Developer of microbiome-based therapeutics | $15.1M | 52/100 | |
8th | Developer of oligonucleotide therapies for neuromuscular diseases | $53M | 51/100 | ||
9th |  Immunis 2018, Irvine (United States), Series A | Developer of cell therapies for age-related and disease-related immune deficits | $55.4M | 48/100 | |
10th |  Remedium Bio 2020, Needham (United States), Seed | Developer of gene therapies for a broad range of diseases | $3.5M | 46/100 | |
24th | Developer of gene therapies for orthopedic treatment | - | 31/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on GQ Bio's competitors? Click here to see the top ones
GQ Bio's Investments and acquisitions
GQ Bio has made no investments or acquisitions yet.
Reports related to GQ Bio
Here is the latest report on GQ Bio's sector:
News related to GQ Bio
Media has covered GQ Bio for 1 event in last 1 year.
•
Pacira BioSciences Acquires Remaining Equity Stake of GQ BioGlobeNewswire•Feb 28, 2025•Pacira, GQ Bio
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about GQ Bio
Explore our recently published companies
- Wayanad Fresh - Wayanad based, 2015 founded, Unfunded company
- R C Agro Foods - Budaun based, 2022 founded, Unfunded company
- Vidina - Santa Monica based, 2019 founded, Unfunded company
- TELUS Digital - Vancouver based, 2005 founded, Unfunded company
- A.R.P. Syndicate - Delhi based, 2022 founded, Unfunded company
- Vagev Vaht - Tallinn based, 2022 founded, Unfunded company
